PHARMAS IN THE DITCH
14/05/25 -"As reverters to the mean, Pharmas have been a waste of time since Covid (say 5 years), over 2 years, 1 year and ytd. This is computed on an equal-weight basis to dampen the Novo Nordisk status shift ..."
Pages
63
Language
English
Published on
14/05/25
You may also be interested by these reports :
15/05/25
KBC delivered a strong Q1, beating consensus on higher fee income and lower provisions, with most metrics tracking 2025 guidance except costs. The ...
14/05/25
ABN beat expectations on lower loan loss provisions and better cost control, aided by reduced consultant use and hiring. While 2025 cost guidance was ...
14/05/25
Post a solid 1Q25, we increase our TP on a lower COE
14/05/25
From screaming BUY to ADD… We published our previous teaser on NatWest (Add; UK) 18 months ago (NWG’s distressed valuation, Nov. 01, 2023) signalling ...